Dilaum Pharma Private Limited
About Dilaum Pharma Private Limited
Data last updated:
Dilaum Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 21 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC169026. Its GSTIN is 27AAGCD0314F1Z6 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ashwini Ashok Marathe and Hardeep Bhalla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – 6 Surbhi Complex M.H.B. Yerwada, Pune, Maharashtra, India – 411006.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.9 Lakh, a decline of 91% compared to the previous year. For the same year it recorded a net loss of ₹1.89 Lakh (net margin -99.4%) and EBITDA of -₹1.79 Lakh (EBITDA margin -94.4%). Revenue has declined at a compounded annual rate (CAGR) of 49% over three years and 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dilaum Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No – 6 Surbhi Complex M.H.B. Yerwada, Pune, Maharashtra, India – 411006
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Dilaum Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Dilaum Pharma Private Limited
FY 2025 filings availableDilaum Pharma Private Limited reported revenue of ₹1.9 Lakh (down 91% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 26% over five years, including a 91% fall in the latest year. EBITDA fell 274% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -94.4% | ||||
| Net Profit Margin | -99.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dilaum Pharma Private Limited, buy the company report.
Board of directors of Dilaum Pharma Private Limited
Dilaum Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwini Ashok Marathe | Director | 21 Feb 2017 | 9 Years 8 Months | Current |
| Hardeep Bhalla Also directs: BGT Consultancy LLP, Earnest Friends of Humanity Foundation | Director | 21 Feb 2017 | 9 Years 8 Months | Current |
Peer comparison
Dilaum Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cosmic Drugs and Chemical Private Limited | ₹1.94 Lakh (FY 2025) | -20.0% | Vadodara, Gujarat, India | |||
| Ganesh Chemical Private Limited | ₹1.93 Lakh (FY 2022) | 12.0% | Mumbai, Maharashtra, India | |||
| Barsana Industries Private Limited | ₹1.93 Lakh (FY 2019) | 36.0% | Vadodara, Gujarat, India | |||
| Gas Supply Company Private Limited | ₹1.92 Lakh (FY 2025) | Delhi, India | ||||
| Swastik Chemioils Pvt Ltd | ₹1.9 Lakh (FY 2025) | Kolkata, West Bengal, India | ||||
| Dilaum Pharma Private Limitedthis company | ₹1.9 Lakh (FY 2024) | -₹1.89 Lakh | -99.4% | -91.0% | Pune, Maharashtra, India | |
| Niyanshi Minerals Private Limited | ₹1.88 Lakh (FY 2023) | -95.0% | Pali, Rajasthan, India | |||
| Northern Borates Private Limited | ₹1.87 Lakh (FY 2025) | -12.0% | Uttar Pradesh, India | |||
| Jammu Mettalic Oxides Private Limited | ₹1.87 Lakh (FY 2025) | -17.0% | Kota, Rajasthan, India | |||
| Epo-Chemie Private Ltd | ₹1.84 Lakh (FY 2024) | 24.0% | Thane, Maharashtra, India | |||
| Sunflower Chemicals Private Limited | ₹1.8 Lakh (FY 2024) | Sivakasi, Tamil Nadu, India |
To see the full peer comparison of Dilaum Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dilaum Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dilaum Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dilaum Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD0314F1Z6 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dilaum Pharma Private Limited, buy the company report.
Recent activity
Dilaum Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Ashwini Ashok Marathe was appointed as Director on 21 Feb 2017.
Frequently asked questions
Dilaum Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 21 February 2017 (9+ years old) and is registered under CIN U74999PN2017PTC169026.
Dilaum Pharma has 2 current directors:
- Ashwini Ashok Marathe - Director
- Hardeep Bhalla - Director
The latest financial statements of Dilaum Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Dilaum Pharma is 27AAGCD0314F1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dilaum Pharma is U74999PN2017PTC169026. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dilaum Pharma was incorporated on 21 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Dilaum Pharma by revenue are Cosmic Drugs and Chemical Private Limited, Ganesh Chemical Private Limited, Barsana Industries Private Limited, Gas Supply Company Private Limited, Swastik Chemioils Pvt Ltd and 5 more, all in the Chemicals industry (Industrial Chemicals).
Ashwini Ashok Marathe was appointed as Director on 21 Feb 2017. Hardeep Bhalla was appointed as Director on 21 Feb 2017.
The registered office of Dilaum Pharma is at Shop No – 6 Surbhi Complex M.H.B. Yerwada, Pune, Maharashtra, India – 411006.
Dilaum Pharma operates in the business services industry, in the other services segment.
The compliance status of Dilaum Pharma is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
